In contrast, PI3K pathway alterations in NHW patients were associated with a trend toward poorer survival (p = 0.09), suggesting that PI3K dysregulation may play a greater prognostic role in NHW HCC patients. The gene discussed is PIK3CB; the disease is hepatocellular carcinoma.